AMPKα1-sensitivity of orai1 and Ca 2+ entry in T - Lymphocytes

Cellular Physiology and Biochemistry

Volumn 32, Issue 3, 2013, Pages 687-698

  Bhavsar, Shefalee K ^a   Schmidt, Sebastian ^a   Bobbala, Diwakar ^a   Nurbaeva, Meerim K ^a   Hosseinzadeh, Zohreh ^a   Merches, Katja ^a   Fajol, Abul ^a   Wilmes, Jan ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

AMP activated protein kinase; Calcium; Orai1; T lymphocytes

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA1; UNCLASSIFIED DRUG; 2 AMINOETHOXYDIPHENYLBORANE; CALCIUM ION; FURA 2; SMALL INTERFERING RNA; STROMAL INTERACTION MOLECULE 1; T LYMPHOCYTE RECEPTOR; THAPSIGARGIN; UBIQUITIN PROTEIN LIGASE NEDD4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM SIGNALING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; CALCIUM CELL LEVEL; ENZYME ACTIVATION; FLOW CYTOMETRY; PROTEIN CROSS LINKING; T LYMPHOCYTE; WESTERN BLOTTING; WILD TYPE;

MUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIBODIES; ANTIGENS, CD3; BORON COMPOUNDS; CALCIUM; CALCIUM CHANNELS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; FURA-2; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL; RNA INTERFERENCE; RNA, SMALL INTERFERING; THAPSIGARGIN;

EID: 84885017512     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354472     Document Type: Article

References (72)

1. Hardie DG: The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci 2004;117: 5479-5487.
2. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG: Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003;2: 28.
3. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D: LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 2003;13: 2004-2008.
4. Zhuo L, Fu B, Bai X, Zhang B, Wu L, Cui J, Cui S, Wei R, Chen X, Cai G: NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway. Cell Physiol Biochem 2011;27: 681-690.
5. Yang D, Yaguchi T, Nakano T, Nishizaki T: Adenosine activates AMPK to phosphorylate Bcl-XL responsible for mitochondrial damage and DIABLO release in HuH-7 cells. Cell Physiol Biochem 2011;27: 71-78.
6. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG: Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2005;2: 9-19.
7. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA: The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 2005;280: 29060-29066.
8. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, Carling D: Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2005;2: 21-33.
9. Ahn YJ, Kim H, Lim H, Lee M, Kang Y, Moon S, Kim HS, Kim HH: AMP-activated protein kinase: implications on ischemic diseases. BMB Rep 2012;45: 489-495.
10. Blagih J, Krawczyk CM, Jones RG: LKB1 and AMPK: central regulators of lymphocyte metabolism and function. Immunol Rev 2012;249: 59-71.
11. Zaha VG, Young LH: AMP-activated protein kinase regulation and biological actions in the heart. Circ Res 2012;111: 800-814.
12. Bijland S, Mancini SJ, Salt IP: Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin Sci (Lond) 2013;124: 491-507.
13. Tamas P, Hawley SA, Clarke RG, Mustard KJ, Green K, Hardie DG, Cantrell DA: Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. J Exp Med 2006;203: 1665-1670.
14. Feske S: Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 2007;7: 690-702.
15. Baba Y, Kurosaki T: Impact of Ca2+ signaling on B cell function. Trends Immunol 2011;32: 589-594.
16. Bortner CD, Cidlowski JA: Life and death of lymphocytes: a volume regulation affair. Cell Physiol Biochem 2011;28: 1079-1088.
17. Qu B, Al-Ansary D, Kummerow C, Hoth M, Schwarz EC: ORAI-mediated calcium influx in T cell proliferation, apoptosis and tolerance. Cell Calcium 2011;50: 261-269.
18. Kane LP, Lin J, Weiss A: Signal transduction by the TCR for antigen. Curr Opin Immunol 2000;12: 242-249.
19. Winslow MM, Neilson JR, Crabtree GR: Calcium signalling in lymphocytes. Curr Opin Immunol 2003;15: 299-307.
20. Heissmeyer V, Macian F, Varma R, Im SH, Garcia-Cozar F, Horton HF, Byrne MC, Feske S, Venuprasad K, Gu H, Liu YC, Dustin ML, Rao A: A molecular dissection of lymphocyte unresponsiveness induced by sustained calcium signalling. Novartis Found Symp 2005;267: 165-174; discussion 174-169.
21. Im SH, Rao A: Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling. Mol Cells 2004;18: 1-9.
22. Schwartz RH: T cell anergy. Annu Rev Immunol 2003;21: 305-334.
23. Rao A, Luo C, Hogan PG: Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997;15: 707-747.
24. Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG: Orai1 is an essential pore subunit of the CRAC channel. Nature 2006;443: 230-233.
25. Putney JW Jr: New molecular players in capacitative Ca2+ entry. J Cell Sci 2007;120: 1959-1965.
26. Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-Huberson M, Kraft S, Turner H, Fleig A, Penner R, Kinet JP: CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 2006;312: 1220-1223.
27. Fahrner M, Muik M, Derler I, Schindl R, Fritsch R, Frischauf I, Romanin C: Mechanistic view on domains mediating STIM1-Orai coupling. Immunol Rev 2009;231: 99-112.
28. Peinelt C, Vig M, Koomoa DL, Beck A, Nadler MJ, Koblan-Huberson M, Lis A, Fleig A, Penner R, Kinet JP: Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat Cell Biol 2006;8: 771-773.
29. Penna A, Demuro A, Yeromin AV, Zhang SL, Safrina O, Parker I, Cahalan MD: The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers. Nature 2008;456: 116-120.
30. Smyth JT, Hwang SY, Tomita T, DeHaven WI, Mercer JC, Putney JW: Activation and regulation of store-operated calcium entry. J Cell Mol Med 2010;14: 2337-2349.
31. Zhang SL, Yu Y, Roos J, Kozak JA, Deerinck TJ, Ellisman MH, Stauderman KA, Cahalan MD: STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature 2005;437: 902-905.
32. Nurbaeva MK, Schmid E, Szteyn K, Yang W, Viollet B, Shumilina E, Lang F: Enhanced Ca2+ entry and Na+/Ca2+ exchanger activity in dendritic cells from AMP-activated protein kinase-deficient mice. FASEB J 2012;26: 3049-3058.
33. Langelueddecke C, Jakab M, Ketterl N, Lehner L, Hufnagl C, Schmidt S, Geibel JP, Fuerst J, Ritter M: Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions. Cell Physiol Biochem 2012;29: 75-86.
34. Mia S, Munoz C, Pakladok T, Siraskar G, Voelkl J, Alesutan I, Lang F: Downregulation of Kv1.5 K channels by the AMP-activated protein kinase. Cell Physiol Biochem 2012;30: 1039-1050.
35. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K, Floride E, Schleicher E, Schulz E, Munzel T, Lang F: Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009;23: 1072-1080.
36. Foretz M, Guihard S, Leclerc J, Fauveau V, Couty JP, Andris F, Gaudry M, Andreelli F, Vaulont S, Viollet B: Maintenance of red blood cell integrity by AMP-activated protein kinase alpha1 catalytic subunit. FEBS Lett 2010;584: 3667-3671.
37. Wang S, Dale GL, Song P, Viollet B, Zou MH: AMPKalpha1 deletion shortens erythrocyte life span in mice: role of oxidative stress. J Biol Chem 2010;285: 19976-19985.
38. Jeyabalan J, Shah M, Viollet B, Roux JP, Chavassieux P, Korbonits M, Chenu C: Mice lacking AMP-activated protein kinase alpha1 catalytic subunit have increased bone remodelling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment. J Endocrinol 2012;214: 349-358.
39. Kang H, Viollet B, Wu D: Genetic deletion of catalytic subunits of AMP-activated protein kinase increases osteoclasts and reduces bone mass in young adult mice. J Biol Chem 2013;288: 23432.
40. Shah M, Kola B, Bataveljic A, Arnett TR, Viollet B, Saxon L, Korbonits M, Chenu C: AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Bone 2010;47: 309-319.
41. Lantier L, Mounier R, Leclerc J, Pende M, Foretz M, Viollet B: Coordinated maintenance of muscle cell size control by AMP-activated protein kinase. FASEB J 2010;24: 3555-3561.
42. Mounier R, Lantier L, Leclerc J, Sotiropoulos A, Foretz M, Viollet B: Antagonistic control of muscle cell size by AMPK and mTORC1. Cell Cycle 2011;10: 2640-2646.
43. Mounier R, Lantier L, Leclerc J, Sotiropoulos A, Pende M, Daegelen D, Sakamoto K, Foretz M, Viollet B: Important role for AMPKalpha1 in limiting skeletal muscle cell hypertrophy. FASEB J 2009;23: 2264-2273.
44. Gayard M, Guilluy C, Rousselle A, Viollet B, Henrion D, Pacaud P, Loirand G, Rolli-Derkinderen M: AMPK alpha 1-induced RhoA phosphorylation mediates vasoprotective effect of estradiol. Arterioscler Thromb Vasc Biol 2011;31: 2634-2642.
45. Goirand F, Solar M, Athea Y, Viollet B, Mateo P, Fortin D, Leclerc J, Hoerter J, Ventura-Clapier R, Garnier A: Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice. J Physiol 2007;581: 1163-1171.
46. Kohlstedt K, Trouvain C, Boettger T, Shi L, Fisslthaler B, Fleming I: AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143/145. Circ Res 2013;112: 1150-1158.
47. Stahmann N, Woods A, Spengler K, Heslegrave A, Bauer R, Krause S, Viollet B, Carling D, Heller R: Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase. J Biol Chem 2010;285: 10638-10652.
48. Wu Y, Zhang C, Dong Y, Wang S, Song P, Viollet B, Zou MH: Activation of the AMP-activated protein kinase by eicosapentaenoic acid (EPA, 20: 5 n-3) improves endothelial function in vivo. PLoS One 2012;7:e35508.
49. Almaca J, Kongsuphol P, Hieke B, Ousingsawat J, Viollet B, Schreiber R, Amaral MD, Kunzelmann K: AMPK controls epithelial Na+ channels through Nedd4-2 and causes an epithelial phenotype when mutated. Pflugers Arch 2009;458: 713-721.
50. Kongsuphol P, Hieke B, Ousingsawat J, Almaca J, Viollet B, Schreiber R, Kunzelmann K: Regulation of Cl-secretion by AMPK in vivo. Pflugers Arch 2009;457: 1071-1078.
51. Sun G, Tarasov AI, McGinty J, McDonald A, da Silva Xavier G, Gorman T, Marley A, French PM, Parker H, Gribble F, Reimann F, Prendiville O, Carzaniga R, Viollet B, Leclerc I, Rutter GA: Ablation of AMP-activated protein kinase alpha1 and alpha2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo. Diabetologia 2010;53: 924-936.
52. Zhang W, Zhang X, Wang H, Guo X, Li H, Wang Y, Xu X, Tan L, Mashek MT, Zhang C, Chen Y, Mashek DG, Foretz M, Zhu C, Zhou H, Liu X, Viollet B, Wu C, Huo Y: AMP-activated protein kinase alpha1 protects against diet-induced insulin resistance and obesity. Diabetes 2012;61: 3114-3125.
53. Tartarin P, Guibert E, Toure A, Ouiste C, Leclerc J, Sanz N, Briere S, Dacheux JL, Delaleu B, McNeilly JR, McNeilly AS, Brillard JP, Dupont J, Foretz M, Viollet B, Froment P: Inactivation of AMPKalpha1 induces asthenozoospermia and alters spermatozoa morphology. Endocrinology 2012;153: 3468-3481.
54. Um JH, Pendergast JS, Springer DA, Foretz M, Viollet B, Brown A, Kim MK, Yamazaki S, Chung JH: AMPK regulates circadian rhythms in a tissue- and isoform-specific manner. PLoS One 2011;6:e18450.
55. Mayer A, Denanglaire S, Viollet B, Leo O, Andris F: AMP-activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function. Eur J Immunol 2008;38: 948-956.
56. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Flamez D, Mu J, Wojtaszewski JF, Schuit FC, Birnbaum M, Richter E, Burcelin R, Vaulont S: Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem Soc Trans 2003;31: 216-219.
57. Sinclair LV, Finlay D, Feijoo C, Cornish GH, Gray A, Ager A, Okkenhaug K, Hagenbeek TJ, Spits H, Cantrell DA: Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol 2008;9: 513-521.
58. Bhavsar SK, Gu S, Bobbala D, Lang F: Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem 2011;27: 547-556.
59. Bhavsar SK, Merches K, Bobbala D, Lang F: AKT/SGK-sensitive phosphorylation of GSK3 in the regulation of L-selectin and perforin expression as well as activation induced cell death of T-lymphocytes. Biochem Biophys Res Commun 2012;425: 6-12.
60. Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A: Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol 2001;2: 316-324.
61. Matza D, Badou A, Jha MK, Willinger T, Antov A, Sanjabi S, Kobayashi KS, Marchesi VT, Flavell RA: Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysis. Proc Natl Acad Sci USA 2009;106: 9785-9790.
62. Srivastava S, Zhdanova O, Di L, Li Z, Albaqumi M, Wulff H, Skolnik EY: Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1. Proc Natl Acad Sci USA 2008;105: 14442-14446.
63. Hock BD, Taylor KG, Cross NB, Kettle AJ, Hampton MB, McKenzie JL: Effect of activated human polymorphonuclear leucocytes on T lymphocyte proliferation and viability. Immunology 2012;137: 249-258.
64. Lee JY, Choi AY, Oh YT, Choe W, Yeo EJ, Ha J, Kang I: AMP-activated protein kinase mediates T cell activation-induced expression of FasL and COX-2 via protein kinase C theta-dependent pathway in human Jurkat T leukemia cells. Cell Signal 2012;24: 1195-1207.
65. Grimaldi C, Chiarini F, Tabellini G, Ricci F, Tazzari PL, Battistelli M, Falcieri E, Bortul R, Melchionda F, Iacobucci I, Pagliaro P, Martinelli G, Pession A, Barata JT, McCubrey JA, Martelli AM: AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. Leukemia 2012;26: 91-100.
66. Tang XX, Chen H, Yu S, Zhang L, Caplan MJ, Chan HC: Lymphocytes accelerate epithelial tight junction assembly: role of AMP-activated protein kinase (AMPK). PLoS One 2010;5:e12343.
67. Gay DL, Ramon H, Oliver PM: Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity. Immunol Res 2008;42: 51-64.
68. Alzamora R, Gong F, Rondanino C, Lee JK, Smolak C, Pastor-Soler NM, Hallows KR: AMP-activated protein kinase inhibits KCNQ1 channels through regulation of the ubiquitin ligase Nedd4-2 in renal epithelial cells. Am J Physiol Renal Physiol 2010;299:F1308-1319.
69. Bhalla V, Oyster NM, Fitch AC, Wijngaarden MA, Neumann D, Schlattner U, Pearce D, Hallows KR: AMP-activated kinase inhibits the epithelial Na+ channel through functional regulation of the ubiquitin ligase Nedd4-2. J Biol Chem 2006;281: 26159-26169.
70. Carattino MD, Edinger RS, Grieser HJ, Wise R, Neumann D, Schlattner U, Johnson JP, Kleyman TR, Hallows KR: Epithelial sodium channel inhibition by AMP-activated protein kinase in oocytes and polarized renal epithelial cells. J Biol Chem 2005;280: 17608-17616.
71. Eylenstein A, Gehring EM, Heise N, Shumilina E, Schmidt S, Szteyn K, Munzer P, Nurbaeva MK, Eichenmuller M, Tyan L, Regel I, Foller M, Kuhl D, Soboloff J, Penner R, Lang F: Stimulation of Ca2+-channel Orai1/STIM1 by serum- and glucocorticoid-inducible kinase 1 (SGK1). FASEB J 2011;25: 2012-2021.
72. Mungai PT, Waypa GB, Jairaman A, Prakriya M, Dokic D, Ball MK, Schumacker PT: Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels. Mol Cell Biol 2011;31: 3531-3545.